Jamie O Musick1, Kirby S Fibben2, Wilbur A Lam1,2. 1. Department of Pediatrics, Aflac Cancer and Blood Disorders Center of Children's Healthcare of Atlanta, Emory University School of Medicine. 2. Wallace H. Coulter Department of Biomedical Engineering, Georgia Institute of Technology and Emory University, Atlanta, Georgia, USA.
Abstract
PURPOSE OF REVIEW: Hyperviscosity syndromes can lead to significant morbidity and mortality. Existing methods to measure microcirculatory rheology are not readily available and limited in relevance and accuracy at this level. In this review, we review selected hyperviscosity syndromes and the advancement of their knowledge using microfluidic platforms. RECENT FINDINGS: Viscosity changes drastically at the microvascular level as the physical properties of the cells themselves become the major determinants of resistance to blood flow. Current, outdated viscosity measurements only quantify whole blood or serum. Changes in blood composition, cell number, or the physical properties themselves lead to increased blood viscosity. Given the significant morbidity and mortality from hyperviscosity syndromes, new biophysical tools are needed and being developed to study microvascular biophysical and hemodynamic conditions at this microvascular level to help predict those at risk and guide therapeutic treatment. SUMMARY: The use of 'lab-on-a-chip' technology continues to rise to relevance with point of care, personalized testing and medicine as customizable microfluidic platforms enable independent control of many in vivo factors and are a powerful tool to study microcirculatory hemorheology.
PURPOSE OF REVIEW: Hyperviscosity syndromes can lead to significant morbidity and mortality. Existing methods to measure microcirculatory rheology are not readily available and limited in relevance and accuracy at this level. In this review, we review selected hyperviscosity syndromes and the advancement of their knowledge using microfluidic platforms. RECENT FINDINGS: Viscosity changes drastically at the microvascular level as the physical properties of the cells themselves become the major determinants of resistance to blood flow. Current, outdated viscosity measurements only quantify whole blood or serum. Changes in blood composition, cell number, or the physical properties themselves lead to increased blood viscosity. Given the significant morbidity and mortality from hyperviscosity syndromes, new biophysical tools are needed and being developed to study microvascular biophysical and hemodynamic conditions at this microvascular level to help predict those at risk and guide therapeutic treatment. SUMMARY: The use of 'lab-on-a-chip' technology continues to rise to relevance with point of care, personalized testing and medicine as customizable microfluidic platforms enable independent control of many in vivo factors and are a powerful tool to study microcirculatory hemorheology.
Authors: Meredith E Fay; David R Myers; Amit Kumar; Cory T Turbyfield; Rebecca Byler; Kaci Crawford; Robert G Mannino; Alvin Laohapant; Erika A Tyburski; Yumiko Sakurai; Michael J Rosenbluth; Neil A Switz; Todd A Sulchek; Michael D Graham; Wilbur A Lam Journal: Proc Natl Acad Sci U S A Date: 2016-02-08 Impact factor: 11.205
Authors: M F A Karel; B M E Tullemans; G D'Italia; T P Lemmens; T A M Claushuis; M J E Kuijpers; J M E M Cosemans Journal: Thromb Res Date: 2022-02-26 Impact factor: 3.944
Authors: Zhongmin Tang; Na Kong; Xingcai Zhang; Yuan Liu; Ping Hu; Shan Mou; Peter Liljeström; Jianlin Shi; Weihong Tan; Jong Seung Kim; Yihai Cao; Robert Langer; Kam W Leong; Omid C Farokhzad; Wei Tao Journal: Nat Rev Mater Date: 2020-10-14 Impact factor: 66.308